Skip to content
healthcare.dev

ANAVIP

NDC 66621-0790, crotalidae immune F(ab)2(equine), injection, powder, lyophilized, for solution, from Rare Disease Therapeutics, Inc.

Product NDC
66621-0790
Status
Listed
Labeler
Rare Disease Therapeutics, Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0790 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)12 mg/mL
Package NDCNDC-11Package
66621-0790-2666210790021 VIAL in 1 CARTON (66621-0790-2) / 10 mL in 1 VIAL (66621-0790-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=66621-0790

Use it

Look up 66621-0790 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66621-0790 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66621-0790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.